Laparoscopic Single-Anastomosis Duodenal-Jejunal Bypass With Sleeve Gastrectomy vs Laparoscopic Duodenal Switch
Launched by MCMASTER UNIVERSITY · Feb 22, 2016
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different types of weight loss surgeries: the laparoscopic Single-Anastomosis Duodenal-Jejunal Bypass with Sleeve Gastrectomy and the laparoscopic Duodenal Switch. The goal is to find out if the first surgery is just as effective or even better for helping people lose weight over a five-year period.
To participate in this trial, you need to be between 18 and 70 years old and meet specific criteria for weight loss surgery, as outlined by the National Institutes of Health. If you're chosen for the study, you can expect to undergo one of these surgical procedures, and your progress will be monitored over the years. It's important to note that individuals with certain health conditions or those who are pregnant or breastfeeding cannot take part in the study. The trial is not yet recruiting, so there will be more information available as it gets started.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Participants must meet ALL of the following inclusion criteria:
- • Fulfilled criteria for bariatric surgery as coined by National Institutes of Health.
- • Their age is ≥18 years and ≤70 years
- • Able and willing to give written consent
- Exclusion Criteria:
- * Participants who meet any of the following criteria at the time of the baseline visit are NOT eligible to be enrolled in this study:
- • Contra-indication to general anesthesia
- • Any medical condition, which in the judgment of the Investigator and/or designee makes the subject a poor candidate for the investigational procedure
- • Pregnant or lactating female (Women of child bearing potential must take a pregnancy test prior to surgery)
- • History of alcohol abuse (\>30 g/day in men or \>20 g/day in women)
About Mcmaster University
McMaster University, a leading research institution located in Hamilton, Ontario, Canada, is renowned for its innovative approach to education and its commitment to advancing healthcare through rigorous clinical research. The university's diverse research programs are supported by a multidisciplinary team of experts dedicated to improving patient outcomes and public health. With a strong emphasis on evidence-based medicine, McMaster University actively engages in clinical trials that explore new therapies, interventions, and health technologies, fostering collaboration among researchers, healthcare professionals, and industry partners to translate findings into real-world applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Dennis Hong, MD FRCSC
Principal Investigator
St. Joseph Healthcare Hamilton, McMaster University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials